TECOmedical develops and offer an extensive range of FDA and EMA approved biomarkers for pre-clinical and clinical studies.
Biomarkers for biosafety studies: Hemocompatibility and CARPA related to activation of the complement-C system in human and animalmodels. Cytotoxicity and drug-induced liver and kidney injury testing as well as Apoptosis and proliferation assays for Anti-Cancer Agent testing.
Furthermore, TECOmedical offers customized test development: ADA, immunogenicity and host cell protein assays.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.